Home > Insider Trading > Filing (0001209191-16-090068)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1435049	Aduro Biotech Inc.	ADRO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1635590	W. Thomas Dubensky	C/O Aduro Biotech, Inc. 626 Bancroft Way, 3C Berkeley CA 94710	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-01-04	6,932	$1.45	6,932	No	4	M	Direct
Common Stock	Acquisiton	2016-01-04	8,068	$7.45	15,000	No	4	M	Direct
Common Stock	Disposition	2016-01-04	11,229	$26.15	3,771	No	4	S	Direct
Common Stock	Disposition	2016-01-04	3,771	$27.02	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-01-04	6,932	$0.00	6,932	$1.45
Common Stock	Stock Option (right to buy)	Disposition	2016-01-04	8,068	$0.00	8,068	$7.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
273,515		2025-01-09	No	4	M	Direct
139,764		2025-03-09	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.70 to $26.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015.
The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of March 6, 2015.